Clock.bio Secures $5.3 Million for Rejuvenation Research
clock.bio, a cutting-edge healthspan biotech company based in Cambridge, UK, has successfully secured an impressive $5.3 million in Seed funding. This funding round was led by the well-known venture firm LocalGlobe, with additional participation from prominent investors such as BlueYard Capital, Onsight Ventures, and Dr. Jonathan Milner, the renowned Founder of Abcam. The financial backing will play a crucial role in advancing clock.bio's ambitious mission: to generate an extensive Atlas of Rejuvenation Factors and initiate further validation processes alongside target prioritization, which are essential for the development of groundbreaking therapies aimed at enhancing human healthspans.
At the helm of clock.
.bio is CEO Markus Gstöttner, alongside CTO Rodrigo Santos and Chairman and co-founder Mark Kotter, all of whom are dedicated to the company's vision of extending the healthy years of human life. Their goal is to develop innovative treatments that not only prevent but also treat age-related diseases by decoding the rejuvenation programs that naturally exist within human cells. The company operates as a collaborative partnership of scientists and operators united by a common ethical perspective, striving to create solutions that can have a profound impact on global health.
Situated within the esteemed Milner Therapeutics Institute at the University of Cambridge, clock.bio is embarking on the intricate task of unraveling the mechanisms of rejuvenation. Their comprehensive research involves running a genome-wide CRISPR screen and utilizing single-cell RNA sequencing techniques to analyze over 3 million cells, generating an astounding 20 terabytes of data in the process. This monumental effort has led to the identification of more than 100 genes that collectively form what they term an “Atlas of Rejuvenation Factors,” establishing a foundation upon which future clinical applications can be built to effectively combat age-related decline.
They've invested in clock.bio
Get to know these Healthtech investors
Click here for a full list of 6,908+ startup investors in the UK